To examine whether circulating IGFBP2 levels are altered during the course of fatty liver disease progression in humans, we measured IGFBP2 serum concentration in men with class III obesity, with histology confirmed hepatic pathological state (HepObster study) [23]. The gene discussed is IGFBP2; the disease is obesity due to melanocortin 4 receptor deficiency.